Q32 Bio Inc., a clinical-stage biotechnology company, develops novel biologics to restore healthy immune balance in patients with alopecia areata and other autoimmune and inflammatory diseases driven by pathological immune dysfunction. The company is developing Bempikibart (ADX-914), a fully human...
4 insider purchases on record · latest filing 2026-06-01.
Insiders have also filed 14 sale transactions at QTTB.